reference/21278886

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21278886

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	456
issn	0007-0920 1532-1827
issueIdentifier	3
pageRange	449-456
publicationName	British Journal of Cancer
startingPage	449
bibliographicCitation	Viens P, Palangié T, Janvier M, Fabbro M, Roché H, Delozier T, Labat JP, Linassier C, Audhuy B, Feuilhade F, Costa B, Delva R, Cure H, Rousseau F, Guillot A, Mousseau M, Ferrero JM, Bardou VJ, Jacquemier J, Pouillart P. First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial). British Journal of Cancer. 1999 Sep 10;81(3):449–56. doi: 10.1038/sj.bjc.6690714.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7818cae86d0df5330a5d110a2f1f4d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5afb15f3112a84a137d461e697b7ed31 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3c290d394a03757d61b50b31d071711 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c968890706a1f76aa56fd08c060a1ee1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43f45c60d76d33cc278eeb07e1929d06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c30c588e10d471d95554bfc628cbb4a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cf34e7784aca24b4a837bbc90263573 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cb0103550a40796710c6c625c5bd926 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf3d09d3ab8fc9a1b90bb081c81252bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2251b03b2d7268c2fe53e0b4dfe6ac3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f1c381213f8d0e8c23f9a950ef87a3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f3b83850450a83374698bf5b3728dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cb3aa1b0065b73ad3a4baefeee0efe1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea5f00a5cc60973446a45d844d72ec04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_22eb75e9279e0cc82582f214247a7056 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1930d41df395249d49b51f76936cf37a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf6a908f5dff0501356d8c210fe79cd5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_676224e39bc94c603d8c5362bca557fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e983c0ad0b5bd90cb90e5e77414d32f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b549b92dc513c65b722f32192c23b4b5
date	1999-09-10^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/sj.bjc.6690714 https://pubmed.ncbi.nlm.nih.gov/10507769 https://pubmed.ncbi.nlm.nih.gov/PMC2362932
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765 https://portal.issn.org/resource/ISSN/0007-0920 https://portal.issn.org/resource/ISSN/1532-1827
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
discusses	http://id.nlm.nih.gov/mesh/M0018641 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0028831 http://id.nlm.nih.gov/mesh/M0024696 http://id.nlm.nih.gov/mesh/M0008631 http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016179Q000627 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D001855Q000628 http://id.nlm.nih.gov/mesh/D018380Q000009 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000401 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018714 http://id.nlm.nih.gov/mesh/D005472Q000009 http://id.nlm.nih.gov/mesh/D005472Q000008 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D001803 http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D000230Q000401 http://id.nlm.nih.gov/mesh/D000230Q000601 http://id.nlm.nih.gov/mesh/D000230Q000532 http://id.nlm.nih.gov/mesh/D008408 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D001855Q000139 http://id.nlm.nih.gov/mesh/D011994 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001943Q000601 http://id.nlm.nih.gov/mesh/D000069585 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D004317Q000009 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D015993 http://id.nlm.nih.gov/mesh/D003520Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D016179Q000009 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D001943Q000532
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11318 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Showing number of triples: 1 to 92 of 92.